Medpace Holdings, Inc.
MEDP
$594.02
$9.111.56%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 9.38% | 8.01% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.38% | 8.01% | |||
| Cost of Revenue | 0.27% | 4.50% | |||
| Gross Profit | 13.43% | 9.65% | |||
| SG&A Expenses | 3.04% | -19.40% | |||
| Depreciation & Amortization | 0.50% | 1.21% | |||
| Other Operating Expenses | 16.49% | 17.33% | |||
| Total Operating Expenses | 8.62% | 7.17% | |||
| Operating Income | 12.25% | 11.29% | |||
| Income Before Tax | 14.69% | 5.39% | |||
| Income Tax Expenses | -7.52% | 858.83% | |||
| Earnings from Continuing Operations | 23.13% | -21.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 23.13% | -21.24% | |||
| EBIT | 12.25% | 11.29% | |||
| EBITDA | 11.63% | 10.71% | |||
| EPS Basic | 25.16% | -16.32% | |||
| Normalized Basic EPS | 16.59% | 11.97% | |||
| EPS Diluted | 24.52% | -15.53% | |||
| Normalized Diluted EPS | 15.99% | 12.81% | |||
| Average Basic Shares Outstanding | -1.63% | -5.88% | |||
| Average Diluted Shares Outstanding | -1.12% | -6.58% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||